Follow
Kristy M. Ainslie
Kristy M. Ainslie
Chair Division of Pharmacoengineering & Molecular Pharmaceutics and Fred Eshelman Distinguished
Verified email at email.unc.edu - Homepage
Title
Cited by
Cited by
Year
Heparan sulfate proteoglycan is a mechanosensor on endothelial cells
JA Florian, JR Kosky, K Ainslie, Z Pang, RO Dull, JM Tarbell
Circulation research 93 (10), e136-e142, 2003
8012003
A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer
N Cheng, R Watkins-Schulz, RD Junkins, CN David, BM Johnson, ...
JCI insight 3 (22), 2018
2322018
In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants
EM Bachelder, TT Beaudette, KE Broaders, JMJ Fréchet, MT Albrecht, ...
Molecular pharmaceutics 7 (3), 826-835, 2010
1582010
Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing
KM Ainslie, TA Desai
Lab on a Chip 8 (11), 1864-1878, 2008
1512008
A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination
RD Junkins, MD Gallovic, BM Johnson, MA Collier, R Watkins-Schulz, ...
Journal of Controlled Release 270, 1-13, 2018
1462018
Acetalated dextran: a tunable and acid-labile biopolymer with facile synthesis and a range of applications
EM Bachelder, EN Pino, KM Ainslie
Chemical reviews 117 (3), 1915-1926, 2017
1452017
In vitro inflammatory response of nanostructured titania, silicon oxide, and polycaprolactone
KM Ainslie, SL Tao, KC Popat, H Daniels, V Hardev, CA Grimes, TA Desai
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2009
1212009
Synthesis and characterization of acetalated dextran polymer and microparticles with ethanol as a degradation product
KJ Kauffman, C Do, S Sharma, MD Gallovic, EM Bachelder, KM Ainslie
ACS applied materials & interfaces 4 (8), 4149-4155, 2012
1042012
Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis
AD Duong, S Sharma, KJ Peine, G Gupta, AR Satoskar, EM Bachelder, ...
Molecular pharmaceutics 10 (3), 1045-1055, 2013
992013
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
CJ Batty, MT Heise, EM Bachelder, KM Ainslie
Advanced drug delivery reviews 169, 168-189, 2021
972021
Electrospray for generation of drug delivery and vaccine particles applied in vitro and in vivo
RT Steipel, MD Gallovic, CJ Batty, EM Bachelder, KM Ainslie
Materials Science and Engineering: C 105, 110070, 2019
902019
Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery
SA Meenach, YJ Kim, KJ Kauffman, N Kanthamneni, EM Bachelder, ...
Molecular pharmaceutics 9 (2), 290-298, 2012
872012
Microfabricated Devices for Enhanced Bioadhesive Drug Delivery: Attachment to and Small‐Molecule Release Through a Cell Monolayer Under Flow
KM Ainslie, RD Lowe, TT Beaudette, L Petty, EM Bachelder, TA Desai
Small 5 (24), 2857-2863, 2009
862009
Acetalated dextran microparticles for codelivery of STING and TLR7/8 agonists
MA Collier, RD Junkins, MD Gallovic, BM Johnson, MM Johnson, ...
Molecular pharmaceutics 15 (11), 4933-4946, 2018
822018
Vascular smooth muscle cell glycocalyx influences shear stress-mediated contractile response
KM Ainslie, JS Garanich, RO Dull, JM Tarbell
Journal of applied physiology 98 (1), 242-249, 2005
822005
Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression
KJ Kauffman, N Kanthamneni, SA Meenach, BC Pierson, EM Bachelder, ...
International journal of pharmaceutics 422 (1-2), 356-363, 2012
802012
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell-and CD8+ T cell-mediated anti-tumor immunity
R Watkins-Schulz, P Tiet, MD Gallovic, RD Junkins, C Batty, ...
Biomaterials 205, 94-105, 2019
792019
Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses
N Chen, MM Johnson, MA Collier, MD Gallovic, EM Bachelder, KM Ainslie
Journal of Controlled Release 273, 147-159, 2018
792018
Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticles
KJ Peine, M Guerau-de-Arellano, P Lee, N Kanthamneni, M Severin, ...
Molecular pharmaceutics 11 (3), 828-835, 2014
782014
PRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitis
LM Webb, SA Amici, KA Jablonski, H Savardekar, AR Panfil, L Li, W Zhou, ...
The Journal of Immunology 198 (4), 1439-1451, 2017
772017
The system can't perform the operation now. Try again later.
Articles 1–20